H2G
0.006
100%
88E
0.001
-50%
RLT
0.76
68.9%
ASP
0.003
-40%
GTR
0.003
50%
GT1
0.038
-34.5%
BEZ
0.035
25%
BP8
0.003
-25%
CXU
0.01
25%
BUY
0.003
-25%
RAC
1.28
24.3%
TMK
0.003
-25%
MLX
0.667
22.4%
CKA
0.04
-21.6%
ELT
0.061
22%
RB6
0.087
-20.9%
SRZ
0.017
21.4%
BSX
0.059
-20.3%
COB
0.066
20%
AAU
0.004
-20%
INF
0.024
20%
PLN
0.12
-17.2%
SRI
0.012
20%
SPQ
0.006
-14.3%
PGO
0.072
18%
STM
0.006
-14.3%
RAS
0.02
17.6%
CBL
0.037
-14%
5EA
0.67
17.5%
NWC
0.019
-13.6%
SRJ
0.034
17.2%
REZ
0.019
-13.6%
FME
0.014
16.7%
RIM
0.026
-13.3%
SIX
0.06
15.4%
ARV
0.007
-12.5%
WOA
0.03
15.4%
AX8
0.007
-12.5%
SHN
0.008
14.3%
GBZ
0.007
-12.5%

The Calmer Co. International (ASX:CCO) generates over $150,000 in sales from its kava-based health drinks now available at Coles

ASX:CCO Share Price

The Calmer Co. International (ASX:CCO) has revealed April ecommerce sales have continued to grow strongly, having now surpassed $11,000 per day.

  • Coles scan sales over the initial launch period exceed $150,000 and were running at over $30,000 per week and greater than 4,600 units per week, in week 8 after launch
  • ecommerce sales continue to grow month-on-month and now exceed $11,000 per day

Anthony Noble, CEO of The Calmer Co. International, says: “Excellence in ecommerce is our primary growth pillar. We have continued to grow month-on-month in these channels, with both Shopify and Amazon contributing.”

“The initial sales results for the new range of three products in Coles are extremely promising and this is now backed up by scan data showing a rapid acceleration in both value of retail sales and units sold across the discount cycle in Coles.”